Skip to main content
. 2017 Nov 1;8(61):102868–102879. doi: 10.18632/oncotarget.22263

Figure 1. Loss of APC leads to increased activation of STAT3.

Figure 1

(A) Western blot analysis demonstrates that MMTV-PyMT;ApcMin/+ cells have increased pSTAT3 but similar levels of total STAT3. (B) Quantification of pSTAT3/STAT3 in MMTV-PyMT;ApcMin/+ vs MMTV-PyMT;Apc+/+ cells shows a significant increase in activated STAT3. (C) Western blot results were confirmed using a dual luciferase reporter assay. Cells were transfected with STAT3 and pRL-TK reporter plasmids for 24 hours and luciferase activity was measured. (D) IL-6 production was measured in media using ELISA, and no difference was observed between MMTV-PyMT;Apc+/+ and MMTV-PyMT;ApcMin/+ cells. (E) Representative western blots for total EGFR show an increase in MMTV-PyMT;ApcMin/+ compared to MMTV-PyMT;Apc+/+ cells. (F) Quantification of EGFR normalized to actin shows that MMTV-PyMT;ApcMin/+ cells express higher levels of EGFR compared to MMTV-PyMT;Apc+/+ cells. (G) Representative western blots for the anti-apoptotic proteins, Bcl-2 and Mcl-1, and quantification (H) shows that Bcl-2 is increased in MMTV-PyMT;ApcMin/+ cells compared to MMTV-PyMT;Apc+/+ cells, while Mcl-1 (I) is unchanged. Actin was used as a loading control for all western blot experiments. Each experiment was repeated 3 times and data are shown as means +/- SD; *P < 0.05 comparing MMTV-PyMT;ApcMin/+ to MMTV-PyMT;Apc+/+ cells.